The Managed Care Review Board™ — An Analysis of Current and Emerging Therapies and Benefit Design Considerations for Psoriasis and Psoriatic Arthritis Web Activity

• Release date: August 18, 2016
• Expiration date: February 28, 2018
• Estimated Time to Complete Activity: 1.75 hours
• Module 1: 0.75 hour
• Module 2: 1.0 hour
• Compatible with all modern browsers and mobile devices

REVIEW BOARD FACULTY

Diana Brixner, RPh, PhD, FAMCP Professor, Department of Pharmacotherapy University of Utah College of Pharmacy Executive Director, Outcomes Research Center Director of Outcomes, Program in Personalized Health Care University of Utah Health Sciences Center Click here for biography James Kenney, RPh, MBA Manager, Specialty and Pharmacy Contracts Harvard Pilgrim Health Care Click here for biography Philip Mease MD Clinical Professor University of Washington School of Medicine Director, Rheumatology Clinical Research Division Swedish Medical Center Click here for biography Kenneth Schaecher, MD, FACP, CPC Medical Director Select Health Click here for biography Paul Yamauchi, MD, PhD Clinical Assistant Professor of Dermatology David Geffen School of Medicine at UCLA Adjunct Associate Professor John Wayne Cancer Institute Dermatology Institute & Skin Care Center, Inc. Clinical Science Institute Click here for biography

TARGET AUDIENCE

• Medical Directors and Pharmacy Directors from health plans, HMOs, integrated health systems, employers, quality organizations, and other managed care organizations (MCOs)
• Managed care-affiliated care team members involved with patient evaluation, education, and follow-up for psoriatic disease patients including: physicians, pharmacists, registered nurses, and case managers

MODULE 1 EDUCATIONAL OBJECTIVES
At the conclusion of this activity, participants should be able to demonstrate improved ability to:

• Assess current and emerging therapies for the treatment of psoriasis and PsA and cite their clinical trial data
• Address nonadherence factors associated with various therapies for psoriasis and PsA

MODULE 2 EDUCATIONAL OBJECTIVES
At the conclusion of this activity, participants should be able to demonstrate improved ability to:

• Analyze the available evidence-base for the treatment of psoriasis and psoriatic arthritis (PsA) in a true CER framework
• Integrate interventions to coordinate health plan and affiliated providers efforts in the health care reform era that will lead to better outcomes for patients with psoriasis and PsA

ACCREDITATION

Physician Continuing Medical Education

Physician Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and Impact Education, LLC. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
The Annenberg Center for Health Sciences at Eisenhower designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

• Module 1: 0.75 CME credits
• Module 2: 1.0 CME credits

Pharmacist Continuing Education

	Pharmacist Accreditation Statement  The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation
This enduring activity has been assigned the following ACPE Universal Activity #s.  This program is designated for up to 1.65 contact hours (0.165 CEUs) of continuing pharmacy education credit.

• Module 1: UAN: #0797-9999-16-039-H04-P, 0.75 contact hour (knowledge)
• Module 2: UAN: #0797-9999-16-038-H04-P, 0.9 contact hour (knowledge)

Nursing Continuing Education

Nursing Accreditation Statement
The Annenberg Center for Health Sciences at Eisenhower is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation
1.5 contact hours may be earned for successful completion of this activity.

• Module 1: 0.7 contact hour
• Module 2: 0.8 contact hour

DISCLOSURE OF CONFLICTS OF INTEREST
The Annenberg Center for Health Sciences at Eisenhower requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to the Annenberg Center for Health Sciences at Eisenhower policy. The Annenberg Center for Health Sciences at Eisenhower is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

METHOD OF PARTICIPATION AND REQUEST FOR CREDIT
There are no fees for participating and receiving CME/CE credit for this activity. During the period of August 18, 2016 through February 28, 2018, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; 3) successfully complete the post-test with a score of 75% or better; 4) and complete the evaluation form. Upon completion of the full CME/CE activity, a certificate will be made available immediately to download and print.

MEDIA
Internet

FEE INFORMATION
There is no fee for this educational activity.